SCHEMBL10429386

SCHEMBL10429386

CC(C)(C)N(C=O)CC(O)COc1ccccc1C1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 3/20 0.60
▸ HTR1A P08908 2/20 0.60
▸ CYP1A2 P05177 2/20 0.60
▸ USP2 O75604 1/20 0.60
▸ CYP2D6 P10635 1/20 0.60
▸ CHRM1 P11229 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60
▸ DRD1 P21728 1/20 0.60
▸ TBXA2R P21731 1/20 0.60
▸ PTGS1 P23219 1/20 0.60
▸ SLC6A2 P23975 1/20 0.60
▸ SLC6A4 P31645 1/20 0.60
▸ ADRA1A P35348 1/20 0.60
▸ OPRM1 P35372 1/20 0.60
▸ DRD3 P35462 1/20 0.60
▸ KCNH2 Q12809 1/20 0.60
▸ PRMT5 O14744 2/20 0.47
▸ WDR77 Q9BQA1 1/20 0.47
▸ PTGDR2 Q9Y5Y4 1/20 0.45
▸ HTR1D P28221 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10429395 0.84 HTR1A (0.63) ADRA2AHTR1ACYP1A2USP2CYP2D6
SCHEMBL13077548 0.76 HTR1A (0.51) ADRA2AHTR1ACYP1A2USP2CYP2D6
SCHEMBL9873335 0.76 HTR1A (0.74) ADRA2AHTR1ACYP1A2USP2CYP2D6
Penbutolol SCHEMBL31572112 0.75 HTR1A (1.00) ADRA2AHTR1ACYP1A2USP2CYP2D6
Penbutolol SCHEMBL30872868 0.75 HTR1A (1.00) ADRA2AHTR1ACYP1A2USP2CYP2D6
Penbutolol SCHEMBL6511962 0.75 HTR1A (1.00) ADRA2AHTR1ACYP1A2USP2CYP2D6
Penbutolol SCHEMBL41408 0.75 HTR1A (1.00) ADRA2AHTR1ACYP1A2USP2CYP2D6
Penbutolol SCHEMBL1652319 0.75 HTR1A (1.00) ADRA2AHTR1ACYP1A2USP2CYP2D6
Penbutolol SCHEMBL29483932 0.75 HTR1A (1.00) ADRA2AHTR1ACYP1A2USP2CYP2D6
Penbutolol SCHEMBL49358 0.75 HTR1A (1.00) ADRA2AHTR1ACYP1A2USP2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4952730-A Process for inverting the configuration of optically active compounds, and optically active intermediates produced in this process HOECHST AKTIENGESELLSCHAFT (DE) 1990-08-28 — — US disclosed
EP-0102520-B1 PROCESS FOR THE INVERSION OF THE CONFIGURATION OF OPTICALLY ACTIVE COMPOUNDS, AND OPTICALLY ACTIVE INTERMEDIATES FOR THIS PROCESS HOECHST AKTIENGESELLSCHAFT (DE) 1986-10-29 — — EP disclosed
EP-0102520-A1 Process for the inversion of the configuration of optically active compounds, and optically active intermediates for this process HOECHST AKTIENGESELLSCHAFT (DE) 1984-03-14 — — EP disclosed
Send feedback